Tissue microarray analysis of the prognostic value of E-cadherin, Ki67, p53, p27, survivin and MSH2 expression in upper urinary tract transitional cell carcinoma

European Urology

Volumn 48, Issue 5, 2005, Pages 764-770

  Fromont, Gaëlle ^b,c   Rouprêt, Morgan ^a,c   Amira, Najla ^c   Sibony, Mathilde ^a   Vallancien, Guy ^b,c   Validire, Pierre ^b   Cussenot, Olivier ^a,c  

^a HÔPITAL TENON   (France)

^b INSTITUT MUTUALISTE MONTSOURIS   (France)

^c UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

Microarray; Prognosis; Renal pelvis; Transitional cell carcinoma; Ureter

Indexed keywords

KI 67 ANTIGEN; PROTEIN MSH2; PROTEIN P27; PROTEIN P53; SURVIVIN; UVOMORULIN;

AGED; ANTIGEN EXPRESSION; ARTICLE; BLADDER METASTASIS; CANCER GRADING; CANCER GROWTH; CANCER INVASION; CANCER MORTALITY; CANCER PATIENT; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; DEMOGRAPHY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PATIENT INFORMATION; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; SMOKING; TISSUE MICROARRAY; TRANSITIONAL CELL CARCINOMA; URINARY TRACT CARCINOMA;

AGED; CADHERINS; CARCINOMA, TRANSITIONAL CELL; DISEASE PROGRESSION; FEMALE; HUMANS; KI-67 ANTIGEN; MALE; MICROARRAY ANALYSIS; MICROTUBULE-ASSOCIATED PROTEINS; MIDDLE AGED; MULTIVARIATE ANALYSIS; MUTS HOMOLOG 2 PROTEIN; NEOPLASM PROTEINS; PROGNOSIS; PROLIFERATING CELL NUCLEAR ANTIGEN; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53; UROLOGIC NEOPLASMS;

EID: 27144511738     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eururo.2005.07.005     Document Type: Article

References (30)

1. M.C. Hall, S. Womack, A.I. Sagalowsky, T. Carmody, M.D. Erickstad, and C.G. Roehrborn Prognostic factors, recurrence, and survival in transitional cell carcinoma of the upper urinary tract: a 30-year experience in 252 patients Urology 52 1998 594 601
2. S. Park, B. Hong, C.S. Kim, and H. Ahn The impact of tumor location on prognosis of transitional cell carcinoma of the upper urinary tract J Urol 171 2004 621 625
3. M. Roupret, G. Fromont, A.R. Azzouzi, J.W. Catto, G. Vallancien, and F.C. Hamdy Microsatellite instability as predictor of survival in patients with invasive upper urinary tract transitional cell carcinoma Urology 65 2005 1233 1237
4. T. Kamai, K. Takagi, H. Asami, Y. Ito, K. Arai, and K.I. Yoshida Prognostic significance of p27 (Kip1) and Ki-67 expression in carcinoma of the renal pelvis and ureter BJU Int 86 2000 14 19
5. K. Nakanishi, T. Kawai, S. Aida, H. Kasamatsu, T. Aurues, and T. Ikeda Expression of p27 (Kip1) protein in transitional cell carcinoma of the upper urinary tract Mod Pathol 14 2001 371 376
6. K. Nakanishi, S. Tominaga, S. Hiroi, T. Kawai, S. Aida, and H. Kasamatsu Expression of survivin does not predict survival in patients with transitional cell carcinoma of the upper urinary tract Virchows Arch 441 2002 559 563
7. R. Zigeuner, O. Tsybrovskyy, M. Ratschek, P. Rehak, K. Lipsky, and C. Langner Prognostic impact of p63 and p53 expression in upper urinary tract transitional cell carcinoma Urology 63 2004 1079 1083
8. J.H. Ku, C. Kwak, H.S. Lee, H.K. Park, E. Lee, and S.E. Lee Expression of survivin, a novel inhibitor of apoptosis, in superficial transitional cell carcinoma of the bladder J Urol 171 2004 631 635
9. A. Rodriguez-Alonso, S. Pita-Fernandez, J. Gonzalez-Carrero, J.L. Nogueira-March, and p53 and ki67 expression as prognostic factors for cancer-related survival in stage T1 transitional cell bladder carcinoma Eur Urol 41 2002 182 188 discussion 188-9
10. J.J. Del Pizzo, A. Borkowski, S.C. Jacobs, and N. Kyprianou Loss of cell cycle regulators p27(Kip1) and cyclin E in transitional cell carcinoma of the bladder correlates with tumor grade and patient survival Am J Pathol 155 1999 1129 1136
11. J.W. Catto, G. Xinarianos, J.L. Burton, M. Meuth, and F.C. Hamdy Differential expression of hMLH1 and hMSH2 is related to bladder cancer grade, stage and prognosis but not microsatellite instability Int J Cancer 105 2003 484 490
12. L. Bubendorf, A. Nocito, H. Moch, and G. Sauter Tissue microarray (TMA) technology: miniaturized pathology archives for high-throughput in situ studies J Pathol 195 2001 72 79
13. P. Watson, and H.T. Lynch The tumor spectrum in HNPCC Anticancer Res 14 1994 1635 1639
14. Genitourinary sites: renal pelvis and ureter G.L. Greene D.L. Page I.D. Fleming AJCC Cancer Staging Manual (AJCC) 2002 Springer Verlag New York 329 330
15. A. Lopez-Beltran, and R. Montironi Non-invasive urothelial neoplasms: according to the most recent WHO classification Eur Urol 46 2004 170 176
16. J. Kononen, L. Bubendorf, A. Kallioniemi, M. Barlund, P. Schraml, and S. Leighton Tissue microarrays for high-throughput molecular profiling of tumor specimens Nat Med 4 1998 844 847
17. M. Morioka, Y. Jo, Y. Furukawa, K. Kinugawa, A. Sone, and T. Matsuki Prognostic factors for survival and bladder recurrence in transitional cell carcinoma of the upper urinary tract Int J Urol 8 2001 366 373
18. S. Holmang, H. Hedelin, C. Anderstrom, E. Holmberg, C. Busch, and S.L. Johansson Recurrence and progression in low grade papillary urothelial tumors J Urol 162 1999 702 707
19. G.D. Stewart, S.V. Bariol, K.M. Grigor, D.A. Tolley, and S.A. McNeill A comparison of the pathology of transitional cell carcinoma of the bladder and upper urinary tract BJU Int 95 2005 791 793
20. Y. Parc, S. Gueroult, N. Mourra, L. Serfaty, J.F. Flejou, and E. Tiret Prognostic significance of microsatellite instability determined by immunohistochemical staining of MSH2 and MLH1 in sporadic T3N0M0 colon cancer Gut 53 2004 371 375
21. A. Ruszkiewicz, G. Bennett, J. Moore, J. Manavis, B. Rudzki, and L. Shen Correlation of mismatch repair genes immunohistochemistry and microsatellite instability status in HNPCC-associated tumours Pathology 34 2002 541 547
22. A. Rey, P.C. Lara, E. Redondo, E. Valdes, and R. Apolinario Overexpression of p53 in transitional cell carcinoma of the renal pelvis and ureter. Relation to tumor proliferation and survival Cancer 79 1997 2178 2785
23. K. Nakanishi, T. Kawai, C. Torikata, T. Aurues, and T. Ikeda E-cadherin expression in upper-urinary-tract carcinoma Int J Cancer 74 1997 446 449
24. W. Sun, and G.A. Herrera E-cadherin expression in urothelial carcinoma in situ, superficial papillary transitional cell carcinoma, and invasive transitional cell carcinoma Hum Pathol 33 2002 996 1000
25. W. Sun, and G.A. Herrera E-cadherin expression in invasive urothelial carcinoma Ann Diagn Pathol 8 2004 17 22
26. W.S. Moon, and A.S. Tarnawski Nuclear translocation of survivin in hepatocellular carcinoma: a key to cancer cell growth? Hum Pathol 34 2003 1119 1126
27. M. Roupret, J.W. Catto, F. Coulet, A.R. Azzouzi, N. Amira, and T. Karmouni Microsatellite instability as indicator of MSH2 gene mutation in patients with upper urinary tract transitional cell carcinoma J Med Genet 41 2004 e91
28. J.W. Catto, A.R. Azzouzi, N. Amira, I. Rehman, K.M. Feeley, and S.S. Cross Distinct patterns of microsatellite instability are seen in tumours of the urinary tract Oncogene 22 2003 8699 8706
29. N. Amira, J. Rivet, H. Soliman, G. Cancel-Tassin, A. Le Duc, and A. Janin Microsatellite instability in urothelial carcinoma of the upper urinary tract J Urol 170 2003 1151 1154
30. J.W. Catto, A.R. Azzouzi, I. Rehman, K.M. Feeley, S.S. Cross, and N. Amira Promoter hypermethylation is associated with tumor location, stage, and subsequent progression in transitional cell carcinoma J Clin Oncol 23 2005 2903 2910